CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · IEX Real-Time Price · USD
2.170
+0.540 (33.13%)
Mar 28, 2024, 11:07 AM EDT - Market open

CERO Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20222021
Cash & Equivalents
6.8219.22
Cash & Cash Equivalents
6.8219.22
Cash Growth
-64.51%-
Other Current Assets
0.260.31
Total Current Assets
7.0819.52
Property, Plant & Equipment
4.274.65
Total Long-Term Assets
4.274.65
Total Assets
11.3524.18
Accounts Payable
0.390.46
Current Debt
0.670.59
Other Current Liabilities
0.10.79
Total Current Liabilities
1.161.84
Long-Term Debt
2.343.02
Other Long-Term Liabilities
0.610.65
Total Long-Term Liabilities
2.953.66
Total Liabilities
4.125.5
Total Debt
3.023.6
Debt Growth
-16.25%-
Retained Earnings
-35.8-23.97
Shareholders' Equity
-34.87-23.43
Net Cash / Debt
3.815.62
Net Cash / Debt Growth
-75.65%-
Net Cash Per Share
0.421.74
Working Capital
5.9117.69
Book Value Per Share
-3.89-2.61
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).